article_metadata: Yukinobu Watanabe Masahiro Ogawa Yu Tamura Seiichiro Suda Masahiro Kaneko Mariko Kumagawa Midori Hirayama Naoki Matsumoto Toshiki Yamamoto Mitsuhiko Moriyama
article_metadata: 10.1177/23247096211058489
article_metadata: J Investig Med High Impact Case Rep
article_metadata: 2021 Jan-Dec;9:23247096211058489.
article_metadata: hepatocellular carcinoma atezolizumab bevacizumab immune checkpoint inhibitor pseudoprogression
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34845921/
article_metadata: Carcinoma, Hepatocellular / drug therapy Chemoembolization, Therapeutic Liver Neoplasms / drug therapy
article_metadata: Carcinoma, Hepatocellular / drug therapy Chemoembolization, Therapeutic Liver Neoplasms / drug therapy Case Reports Aged Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols / therapeutic use Bevacizumab / therapeutic use Humans Male Antibodies, Monoclonal, Humanized Bevacizumab atezolizumab
article_metadata: PMC8637399
article_metadata: 34845921
article_metadata: A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
article_metadata: 2021